Search

Search Results

• PO:02:021 | Sustained Improvements with Bimekizumab in Pain, Morning Stiffness, Fatigue, Physical Function and Health-Related Quality of Life in Patients with Axial Spondyloarthritis: 3-Year Results from Two Phase 3 Studies Victoria Navarro-Compán¹, Uta Kiltz^2|3, Philip J Mease⁴, Maureen Dubreuil⁵, Karl Gaffney⁶, Atul Deodhar⁷, Christine De La Loge⁸, Diana Voiniciuc⁹, Jason Coarse¹⁰, Ilaria Spadafora¹¹, Helena Marzo-Ortega¹² | ¹La Paz University Hospital, IdiPaz, Department of Rheumatology Madrid Spain; ²Ruhr-University Bochum Bochum Germany; ³Rheumazentrum Ruhrgebiet Herne, Germany; ⁴Department of Rheumatology, Swedish Medical Center and Providence St. Joseph Health and University of Washington Seattle, USA; ⁵Boston University School of Medicine, Department of Rheumatology Boston, USA; ⁶Norfolk and Norwich University Hospital NHS Trust, Department of Rheumatology Norfolk, United Kingdom; ⁷Oregon Health and Science University, Division of Arthritis and Rheumatic Diseases Portland, USA; ⁸UCB Brussels, Belgium; ⁹UCB Slough, United Kingdom; ¹⁰UCB Morrisville, USA; ¹¹UCB Milan, Italy; ¹²NIHR Leeds Biomedical Research Centre, University of Leeds Leeds, United Kingdom

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2284

  72

• PO:02:022 | Bimekizumab Maintained Stringent Clinical Responses over 2 Years in Patients with Axial Spondyloarthritis: Results from Two Phase 3 Studies Fabian Proft¹, Désirée Van Der Heijde², Sergio Schwartzman^3|4|5, Joerg Ermann⁶, Alexander Marten⁷, Ute Massow⁷, George Stojan⁸, Vanessa Taieb⁹, Diana Voiniciuc¹⁰, Astrid Van Tubergen¹¹, Victoria Navarro-Compán¹², Simone Angioni¹³, Xenofon Baraliakos¹⁴ | ¹Charité-Universitätsmedizin Berlin; Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany; ²Department of Rheumatology, Leiden University Medical Center Leiden, The Netherlands; ³Weill Cornell Medical Center New York, USA; ⁴New York Presbyterian Hospital New York, USA; ⁵Hospital for Special Surgery New York, USA; ⁶Division of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital and Harvard Medical School Boston, USA; ⁷UCB Monheim am Rhein Germany; ⁸UCB Atlanta, USA; ⁹UCB Colombes, France; ¹⁰UCB Slough, United Kingdom; ¹¹Department of Medicine, Division of Rheumatology, Maastricht University Medical Center Maastricht, The Netherlands; ¹²Department of Rheumatology, La Paz University Hospital, IdiPaz Madrid, Spain; ¹³UCB Milan, Italy; ¹⁴Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Germany

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2285

  63